Study of functional dipeptide on the avoidance of functional brain aging

Study of functional dipeptide on the avoidance of functional brain aging - Study of functional dipeptide

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032319

Enrollment

Registered

2018-04-20

Start date

2018-04-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly person including MCI individual

Interventions

Functional dipeptide 0.5g per day for 12 weeks Placebo control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy elderly person including MCI individual

Exclusion criteria

Exclusion criteria: Dementia patients

Design outcomes

Primary

Measure	Time frame
The score of neuropsychiatric test evaluating age-related cogntive declines	—

Countries

Japan

Contacts

Public ContactTatsuhiro Hisatsune

The University of Tokyo GSFS

hisatsune@edu.k.u-tokyo.ac.jp04-7136-3632

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026